|
Name |
(1R,2S,12R,15R)-1-hydroxy-2,7-dimethoxy-12-(2-methylprop-1-enyl)-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4(9),5,7-tetraene-14,20-dione
|
Molecular Formula | C23H27N3O5 | |
IUPAC Name* |
(1R,2S,12R,15R)-1-hydroxy-2,7-dimethoxy-12-(2-methylprop-1-enyl)-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4(9),5,7-tetraene-14,20-dione
|
|
SMILES |
CC(=C[C@@H]1C2=C([C@@H]([C@@]3(N1C(=O)[C@H]4CCCN4C3=O)O)OC)C5=C(N2)C=C(C=C5)OC)C
|
|
InChI |
InChI=1S/C23H27N3O5/c1-12(2)10-17-19-18(14-8-7-13(30-3)11-15(14)24-19)20(31-4)23(29)22(28)25-9-5-6-16(25)21(27)26(17)23/h7-8,10-11,16-17,20,24,29H,5-6,9H2,1-4H3/t16-,17-,20+,23-/m1/s1
|
|
InChIKey |
DARSEBUZHJPBHI-TVLQYADYSA-N
|
|
Synonyms |
CYCLOTRYPROSTATIN B
|
|
CAS | NA | |
PubChem CID | 102379066 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 425.5 | ALogp: | 1.6 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 95.1 | Aromatic Rings: | 5 |
Heavy Atoms: | 31 | QED Weighted: | 0.737 |
Caco-2 Permeability: | -4.833 | MDCK Permeability: | 0.00000834 |
Pgp-inhibitor: | 0.999 | Pgp-substrate: | 0.928 |
Human Intestinal Absorption (HIA): | 0.213 | 20% Bioavailability (F20%): | 0.267 |
30% Bioavailability (F30%): | 0.986 |
Blood-Brain-Barrier Penetration (BBB): | 0.105 | Plasma Protein Binding (PPB): | 75.54% |
Volume Distribution (VD): | 1.276 | Fu: | 11.32% |
CYP1A2-inhibitor: | 0.019 | CYP1A2-substrate: | 0.266 |
CYP2C19-inhibitor: | 0.395 | CYP2C19-substrate: | 0.863 |
CYP2C9-inhibitor: | 0.44 | CYP2C9-substrate: | 0.353 |
CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.153 |
CYP3A4-inhibitor: | 0.687 | CYP3A4-substrate: | 0.935 |
Clearance (CL): | 5.71 | Half-life (T1/2): | 0.635 |
hERG Blockers: | 0.038 | Human Hepatotoxicity (H-HT): | 0.98 |
Drug-inuced Liver Injury (DILI): | 0.986 | AMES Toxicity: | 0.017 |
Rat Oral Acute Toxicity: | 0.591 | Maximum Recommended Daily Dose: | 0.943 |
Skin Sensitization: | 0.22 | Carcinogencity: | 0.181 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
Respiratory Toxicity: | 0.94 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001958 | 0.837 | D0J4JM | 0.296 | ||||
ENC003264 | 0.837 | D0G8NJ | 0.293 | ||||
ENC002846 | 0.740 | D06YFA | 0.281 | ||||
ENC002064 | 0.640 | D02IQY | 0.258 | ||||
ENC002274 | 0.618 | D01XNB | 0.254 | ||||
ENC001060 | 0.618 | D0C6DT | 0.254 | ||||
ENC003013 | 0.613 | D01TSI | 0.251 | ||||
ENC000837 | 0.596 | D09HDR | 0.250 | ||||
ENC005479 | 0.555 | D0P0RX | 0.250 | ||||
ENC002042 | 0.547 | D00XHD | 0.244 |